Anteris Technologies Global
AVR
4.99
-0.10
-1.96%
Anteris Technologies Global
US · AVR
#3553 by market cap
Listed 2024
4.99
-0.10
-1.96%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Anteris Technologies Raised to Buy From Spec Buy by Bell Potter AVR.AUDow Jones · 2026/3/9
-
Rating change
Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $18Market Newswire · 2026/5/15
-
Rating change
Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)TipRanks · 2026/6/1
-
Rating change
Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $22Market Newswire · 2026/2/24
-
Anteris Technologies Global Corp. (AVR) Gets a Buy From Cantor FitzgeraldTipRanks · 2026/10/14
-
Rating change
Wells Fargo Initiates Anteris Technologies Global(AVR.US) With Buy Rating, Announces Target Price $16Market Newswire · 2026/3/11
-
Rating change
Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)TipRanks · 2026/5/4
-
Rating change
TD Cowen Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $15Market Newswire · 2026/6/30
-
Rating change
Cantor Fitzgerald Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)TipRanks · 2026/5/14
-
Rating change
Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)TipRanks · 2026/5/15
-
Barclays Maintains Anteris Technologies Global(AVR.US) With Hold Rating, Cuts Target Price to $9Market Newswire · 2026/11/13
-
Anteris Technologies Global(AVR.US) 10% Shareholder Buys US$6.71 Million in Common StockMarket Newswire · 2026/10/6
-
Rating change
Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Cuts Target Price to $17Market Newswire · 2026/3/12
-
Wells Fargo Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/11/13
-
Rating change
Barclays Downgrades Anteris Technologies Global(AVR.US) to Hold Rating, Cuts Target Price to $10Market Newswire · 2026/10/7
-
Rating change
Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Kymera Therapeutics (KYMR)TipRanks · 2026/6/26
-
Rating change
Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR)TipRanks · 2026/8/14
-
Rating change
Analysts Conflicted on These Healthcare Names: Anteris Technologies Global Corp. (AVR), Lifecore Biomedical (LFCR) and Biogen (BIIB)TipRanks · 2026/6/18
-
Rating change
Analysts Offer Insights on NA Companies: BETA Technologies, Inc. Class A (BETA) and Anteris Technologies Global Corp. (AVR)TipRanks · 2026/8/13
-
Barclays Initiates Anteris Technologies Global(AVR.US) With Hold Rating, Announces Target Price $10Market Newswire · 2026/10/8
-
Rating change
Wells Fargo Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/8/13
-
Anteris Technologies Global(AVR.US) 10% Shareholder Buys US$3.03 Million in Common StockMarket Newswire · 2026/10/2
-
Anteris Technologies Global(AVR.US) 10% Shareholder Sells US$5.79 Million in Common StockMarket Newswire · 2026/8/12
-
Rating change
Anteris Technologies Global Corp. (AVR) Gets a Buy From BarclaysTipRanks · 2026/2/24
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Anteris Technologies Global discussion 0 comments